单侧左侧胸腔镜心房颤动消融联合微创左前降支旁路移植术
本研究回顾性分析2017至2021年马斯特里赫特大学医学中心23例心房颤动合并左前降支临界狭窄患者,行单侧左侧胸腔镜房颤消融联合非体外循环微创直接冠状动脉旁路移植术。术后12个月81%患者维持窦性心律(允许抗心律失常药物),左心房射血分数由26%提高至38%(P=0.01)。作者认为该联合术式在初始可行性及早期安全性研究中可行、安全且有效。
要点
- 单侧左侧胸腔镜房颤消融联合微创左前降支旁路移植术在23例患者中可行。
- 术后12个月81%患者维持窦性心律(允许使用抗心律失常药物)。
- 左心房射血分数术后由26%提高至38%(P=0.01)。
核心结论
- 作者认为,在初始可行性及早期安全性研究中,单侧左侧胸腔镜房颤消融联合微创直接冠状动脉旁路移植术行左乳内动脉-左前降支移植,对心房颤动合并左前降支临界狭窄患者可行、安全且有效。
研究设计与样本
- 回顾性分析前瞻性收集的队列,纳入2017至2021年马斯特里赫特大学医学中心所有连续的心房颤动合并至少左前降支临界狭窄、接受单侧左侧胸腔镜房颤消融联合非体外循环微创直接冠状动脉旁路移植术的患者,共23例。
主要发现
- 患者年龄69岁(标准差=8),阵发性心房颤动61%,左心房容积指数42 ml/m2(标准差=11)。
- 单侧左侧胸腔镜射频消融完成左肺静脉隔离23例、右肺静脉隔离22例、box消融21例,其中心外膜验证出口和入口阻滞22例。
- 围术期并发症包括1例胸廓切开伤口出血和1例无需干预的顿挫型心肌梗死。
- 平均住院时间6天(标准差=2)。
- 出院后1年内4例患者因心脏原因再入院(心房颤动1例;胸腔和心包积液2例;需经皮介入左乳内动脉-左前降支的心肌梗死1例)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Thoracoscopic ablation for atrial fibrillation (AF) and minimally invasive direct coronary artery bypass (MIDCAB) with robot-assisted left internal mammary artery (LIMA) harvesting may represent a safe and effective alternative to more invasive surgical approaches via sternotomy. The aim of our study was to describe the feasibility, safety and efficacy of a unilateral left-sided thoracoscopic AF ablation and concomitant MIDCAB surgery. METHODS: Retrospective analysis of a prospectively gathered cohort was performed of all consecutive patients with AF and at least a critical left anterior descending artery (LAD) stenosis that underwent unilateral left-sided thoracoscopic AF ablation and concomitant off-pump MIDCAB surgery in the Maastricht University Medical Centre between 2017 and 2021. RESULTS: Twenty-three patients were included [age 69 years (standard deviation = 8), paroxysmal AF 61%, left atrial volume index 42 ml/m2 (standard deviation = 11)]. Unilateral left-sided thoracoscopic isolation of the left (n = 23) and right (n = 22) pulmonary veins and box (n = 21) by radiofrequency ablation was succeeded by epicardial validation of exit- and entrance block (n = 22). All patients received robot-assisted LIMA harvesting and off-pump LIMA-LAD anastomosis through a left mini-thoracotomy. The perioperative complications consisted of one bleeding of the thoracotomy wound and one aborted myocardial infarction not requiring intervention. The mean duration of hospital stay was 6 days (standard deviation = 2). After discharge, cardiac hospital readmission occurred in 4 patients (AF n = 1; pleural- and pericardial effusion n = 2, myocardial infarction requiring the percutaneous intervention of the LIMA-LAD n = 1) within 1 year. After 12 months, 17/21 (81%) patients were in sinus rhythm when allowing anti-arrhythmic drugs. Finally, the left atrial ejection fraction improved postoperatively [26% (standard deviation = 11) to 38% (standard deviation = 7), P = 0.01]. CONCLUSIONS: In this initial feasibility and early safety study, unilateral left-sided thoracoscopic AF ablation and concomitant MIDCAB for LIMA-LAD grafting is a feasible, safe and efficacious for patients with AF and a critical LAD stenosis.
引用
- van der Heijden CAJ, Segers P, Masud A, et al. Unilateral left-sided thoracoscopic ablation of atrial fibrillation concomitant to minimally invasive bypass grafting of the left anterior descending artery. Eur J Cardiothorac Surg. 2022. PMID: 35947693. doi:10.1093/ejcts/ezac409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。